Table 2:

Moderators of effect size magnitude for ART adherence outcomes

Moderator	Beta	p-value	k	mean
Publication Year	0.24	0.36		2010
Developing Country	0.5	0.043	7
Sample Size	−0.01	0.97		104.23
Methodological Quality	0.11	0.68		17.79
Recruitment
By Flyer	0.66	0.001	2
In Clinic	−0.76	<0.001	12
Through Community Based Organizations/Support Groups	−0.25	0.34	3
Inclusion Criteria
Pregnant	−0.17	0.52	2
Mental Health Issues	−0.29	0.27	2
Acceptance Rate	0.04	0.91		62.58%
Attrition Rate	0.55	0.02		79.32%
Baseline Characteristics
Age	−0.33	0.2		35.23
Completed Secondary Education	−0.55	0.03		61.46%
Single	−0.5	0.1		34.38%
Theory-Based	−0.15	0.59	4
Group Component	0.47	0.049	7
Control Group
Standard of Care Control/No intervention	0.32	0.22	7
Intervention Not Related to Adherence	−0.29	0.27	5
Intervention Length (Days)	0.05	0.85		130
Number of Intervention Sessions	0.28	0.31		17
Length of Follow-up (weeks)	0.3	0.25		13.7
Type of Intervention
Technology-based	−0.33	0.2	4
Information/education	0.23	0.39	6
Motivational	−0.06	0.82	3
Cognitive-behavioral	−0.13	0.63	8
Alteration of the healthcare system	0.53	0.02	2
Intervention Content
Gender Empowerment	0.01	0.97	2
Cultural Relevance/Tailoring	0.01	0.97	2
Role Playing/Skills building	−0.32	0.22	6
Feedback	−0.11	0.68	1
Goal Setting	−0.09	0.74	3
Discussion of barriers/facilitators/strategies	0.34	0.18	8
Coping	0.08	0.77	5
Symptom management	−0.13	0.62	2
Adherence Measure Characteristics
Self report	−0.46	0.64	8
Wisepill	−1.05	0.29	2
Pill count	0.65	0.002	4
30 day reference period	0.31	0.24	4
7 day reference period	−0.04	0.87	4